The Peptide NewsroomPeptide research, industry and supply-chain headlines

Endocrinologist Calls Peptide Injections Biochemically Interesting, But Says Human Evidence Is Missing

Topic card: skin-beauty muscle

A report from RTE examines the boom in self-administered peptide injections promoted on social media, where users advertise faster muscle growth, weight loss and better skin, and asks what is actually known about the risks.

Peptides are chains of amino acids that occur naturally in the body. Christian Seifarth, founder and managing director of the Bavarian Centre for Endocrinology and Metabolism, describes them as proteins with signalling properties that trigger specific processes, acting as hormones, neurotransmitters or growth factors that regulate bodily functions and promote cell growth and tissue repair.

Why the mechanism cuts both ways

Seifarth says peptides are not dangerous in themselves, since the body produces many of these signalling molecules on its own. That is not an argument for synthetic versions being harmless, and he is blunt about why: the danger lies in the effect, because these substances act specifically on organs and structures, and there is always a downside.

He draws a line between a molecule the body makes in a particular place and the same molecule injected into an abdomen or an upper arm. Those are not the same event, and the report treats that distinction as the core of the safety question rather than a footnote.

Who is watching the trend

Tami, 31, injects peptides and has spent a year collecting data on different preparations, posting about her experiences and the potential risks. Within the TikTok bubble, she says, a lot of it sounds like established science, but a closer look at the studies shows many findings come from animal experiments or cell cultures.

She receives messages from users aged 13 to 17, some reporting fever, redness or bruising after use and asking for advice. Her answer is the right one: anyone who develops a fever should see a doctor, not post on a forum. Seifarth flags the same age group specifically, warning that growth could be affected and puberty disrupted.

Marketing in a lab coat

Tami's phrase for the sales pitch, in the absence of meaningful human trials, is marketing in a lab coat. Seifarth adds a physical risk that the content rarely mentions: preparations could be contaminated with bacteria, and injecting them could mean an infection.

He is dismissive of the anti-aging logic in particular, comparing it to hormone preparations of the 1990s and calling the approaches highly questionable.

Bottom line

Seifarth calls peptides very interesting biochemically and says they do have potential. His conclusion is that it is far too early to use them in people, because too little is known to do so responsibly.

Source: RSS.app — Peptides bundle. Read the original.

Filed under: skin-beauty, muscle, safety

Comments (0)

Discussion happens on Reddit.
Questions and corrections go to r/PeptideNewsroom.

Go to r/PeptideNewsroom

Corrections are the most useful thing you can post. Comments touching dosing, sourcing or links are held for a moderator first.

More from The Peptide Newsroom

J&J Says Oral Peptide Icotrokinra Beat Placebo in Psoriatic Arthritis, But Approval Is Not There Yet

Johnson & Johnson reported Phase 3 results for the oral peptide icotrokinra in psoriatic arthritis, with 58% of patients reaching an ACR20 response at Week 16 against 41% on placebo. The data come from a conference poster, the drug is not approved for the condition, and the later figures have no placebo comparator.

HHS Draft Policy Names MOTS-c, But the Peptide Is Still Not FDA-Approved

A California clinic's press release highlights MOTS-c's inclusion in a draft HHS enforcement-discretion policy for 503A peptide compounding, published October 30, 2026. The framework covers six peptides and explicitly does not make any of them FDA-approved.

RFK Jr. Eases Access to Unproven Peptides, But FDA Scientists Pushed Back Hard

A draft HHS policy would ease access to a handful of injectable peptides marketed for muscle, injury recovery and energy, over opposition from FDA scientific staff. A UNLV hematologist laid out the timeline and the risks on local television as a two-week comment window opened.